However, this effect appears to be cell/cancer-type specific, as the over-expression of PRMT6 in human estrogen-sensitive breast cancer cells (MCF7) and the human prostate cancer cells (PC3) increases the TSP-1 expression and hence inhibits the movement and invasion of cancer cells [86]. This evidence concerns the gene PRMT6 and breast carcinoma.